Sotac Pharmaceuticals
SOTAC · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.2%
1w
0.2%
1m
2.3%
3m
14.4%
6m
17.6%
1y
20.8%
all
25.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 89.8 0.2%
85.8
110
Company Overview

Sales
95.6 Cr
Growth: 21.8%
Profit after Tax
4.01 Cr
Growth: 29.6%
Micro Cap
99.3 Cr
P/E: 26.1x
Industry P/E: 35.3x
Fundamentals

Sales (Cr) ₹ 95.6
Growth 21.8%
EBITDA 9.7%
P/S 1.0x
Dividend 0.1%
P/E 26.1x
Book Value ₹ 42.3
PEG Ratio 1.2x
ROE 19.1%
P/B 2.1x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products. Key Events/Milestone/ Achievement2015: The company was incorporated as a private limited company under the name Sotac Pharmaceuticals Private Limited.
Belongs to (1 Indices)